Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederpubmed.ncbi.nlm.nih.gov
Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat]
Get the latest updates from Durva OR Treme OR Pembrolizumab OR nivolumab OR atezolizumab OR sasanlimab OR tarlatamab AND lung cancer AND 2025:2025[pdat] AND 2025:2025[pdat] directly as they happen.
Follow now 166 followers
Latest posts
Last updated 4 days ago
Acute esophageal mucosal injury during pembrolizumab treatment after a hypopharyngeal cancer patient's free jejunal autograft reconstruction, as an immune-related adverse event
4 days ago
Int Cancer Conf J. 2025 Nov 6;15(1):86-91. doi: 10.1007/s13691-025-00822-6. eCollection 2026 Jan.ABSTRACTThe...
Rapidly progressive and fatal drug-induced interstitial pneumonitis after three cycles of enfortumab vedotin plus pembrolizumab treatment for metastatic urothelial carcinoma: a case report
4 days ago
Int Cancer Conf J. 2025 Dec 12;15(1):166-169. doi: 10.1007/s13691-025-00837-z. eCollection 2026 Jan.ABSTRACTEnfortumab...
No More Detours: Hepatopulmonary Shunt Reduction in a Patient with Hepatocellular Carcinoma after Treatment with Bevacizumab
8 days ago
Liver Cancer. 2025 Dec 22. doi: 10.1159/000548565. Online ahead of print.ABSTRACTINTRODUCTION: Treatment...
Case Report: Pembrolizumab associated lichen planus in early stage triple negative breast cancer
8 days ago
Front Oncol. 2026 Jan 7;15:1726097. doi: 10.3389/fonc.2025.1726097. eCollection 2025.ABSTRACTTriple negative breast cancer...
Predictive value of circulating microRNA-21 levels in patients with advanced non-small cell lung cancer treated with immunotherapy
10 days ago
Ecancermedicalscience. 2025 Sep 16;19:1989. doi: 10.3332/ecancer.2025.1989. eCollection 2025.ABSTRACTBACKGROUND: Pembrolizumab has been widely...
A Case of Advanced Gastric Cancer with Postoperative Multiple Metastasis, That Obtained Long-Term Survival after Multimodal Therapy
14 days ago
Gan To Kagaku Ryoho. 2025 Dec;52(13):927-929.ABSTRACTAn 82-year-old female was referred of vomiting...
A Case of Simultaneous Resection of Single Lung and Liver Metastases with Combined Immunotherapy after Radical Surgery for Hepatocellular Carcinoma
14 days ago
Gan To Kagaku Ryoho. 2025 Dec;52(13):1100-1103.ABSTRACTThe patient is a 66-year-old man. He...
Robot-Assisted Mediastinoscopic Esophagectomy Following Immunotherapy-Induced Interstitial Pneumonia in a High-Risk Patient with Esophageal Cancer
14 days ago
Gan To Kagaku Ryoho. 2025 Dec;52(13):1050-1052.ABSTRACTWe report here a successfully treated case...
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab Use
15 days ago
Clin Lung Cancer. 2025 Dec 2;27(2):48-58. doi: 10.1016/j.cllc.2025.11.018. Online ahead of print.ABSTRACTPURPOSE...
Severe Anti-CV2/CRMP5, Anti-Hu, and Anti-SOX1 Antibody-Positive Paraneoplastic Neurological Syndrome Associated With Tumor Recurrence During Atezolizumab Therapy
15 days ago
Cureus. 2025 Dec 14;17(12):e99224. doi: 10.7759/cureus.99224. eCollection 2025 Dec.ABSTRACTWe report a case...
A Retrospective Study of First-Line Immunotherapy for Advanced Non-Small Cell Lung Cancer in the Elderly
17 days ago
Aging Med (Milton). 2025 Dec 26;8(6):592-611. doi: 10.1002/agm2.70052. eCollection 2025 Dec.ABSTRACTOBJECTIVES: In...
Capturing durable benefits: interpreting six-year treatment-free survival and restricted mean survival time in CheckMate 227
19 days ago
J Thorac Dis. 2025 Dec 31;17(12):10600-10604. doi: 10.21037/jtd-2025-aw-2095. Epub 2025 Dec 29.NO...